ClinicalTrials.gg
CompletedNCT02871999Updated Jan 25, 2019

Clinical Trial on Acupuncture Adjuvant Treatment in the Pain After the Surgery of Gastrointestinal Carcinoma

An interventional study of Acupuncture therapy and Laparoscopic Surgery in Gastrointestinal Carcinoma and Pain, sponsored by Xiaonan Cui. Completed. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2019-01-25.

Sponsored by Xiaonan Cui · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

Clinical trial on acupuncture adjuvant treatment in the pain after the surgery of gastrointestinal carcinoma. Gastrointestinal cancer patients are diagnosed by pathology or cell biology. Patients are randomized into 2 groups: The control group receive normal treatment only, the experimental group receive acupuncture therapy besides normal treatment. Clinical evaluation is based on the observation of the pain degree and life quality improvement. Blood biochemistry tests mainly include Prostaglandin E2(PGE2),5-hydroxytryptamine(5-HT), histamine(HIS), malondialdehyde (MDA), superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), adrenaline, nor-adrenaline, tumor necrosis factor (TNF)-α, cell flow cytometry on Th1, Th2, Th17, Treg cytokines as well as serum cortisol, estradiol (female), progesterone (female), testosterone (male) etc.

02

Conditions studied

  • Gastrointestinal Carcinoma
  • Pain

Browse trials for

Keywords

  • Acupuncture Therapy
  • Pain degree after surgery
03

In context

Pain

10,076 studies on the registry are indexed under Pain; 1,648 are open to participants now.

This study's enrollment of 60 is close to the median of 66 across 8,512 interventional studies indexed under Pain.

Browse Pain studies →

Lead sponsor

Xiaonan Cui is the lead sponsor of 4 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. General anesthesia,Gastric and Colorectal Cancer surgery under Laparoscopic;
  2. Pathology diagnosed;
  3. Brain, heart, lung, liver, kidney are at good condition before surgery;
  4. No mental disorder, no conscious obstacle, no limbs disability.

Exclusion criteria

Exclusion Criteria:

  1. Severely complication after surgery;
  2. of the acupuncture;
  3. Patients with mental disease;
  4. Patients taking part in other clinical trials, being treated with other biotherapy or immunotherapy and researchers consider not suitable for clinical subjects for other reasons will be excluded.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (actual)

Study arms

  • Active comparator
    Control group

    This group receives normal treatment after surgery,with no acupuncture.

    Procedure: Laparoscopic Surgery

  • Experimental
    Experimental group

    This group receives acupuncture therapy besides normal treatment after surgery. The acupuncture therapy starts after 24 hours of surgery, 1 time a day, 30 minutes every time, until the fifth day.

    Device: Acupuncture therapy · Procedure: Laparoscopic Surgery

Interventions

  • DeviceAcupuncture therapy
  • ProcedureLaparoscopic Surgery
06

What researchers measure

Primary outcomes

  1. Pain degree change after surgery, Graded according to Numerical Rating Scale(NRS)

    Time frame: day 1, day 2, day 3, day 4, day 5, day 6, day 7 after surgery

Secondary outcomes

  1. Assessing the quality of life(QOL) change in 4 grades and recording: appetite, mental state, sleep, fatigue, attitude towards treatment, daily life ability

    Time frame: day 1, day 2, day 3, day 4, day 5, day 6, day 7 after surgery

  2. Prostaglandin E2(PGE2) in blood

    Time frame: day 2,day 7 after surgery

  3. Estradiol(Female) in blood

    Time frame: day 2, day 7 after surgery

  4. Th1/Th2 in blood

    Time frame: day 2, day 7 after surgery

  5. 5-Hydroxytryptamine(5-HT) in blood

    Time frame: day 2,day 7 after surgery

  6. Histamine(HIS) in blood

    Time frame: day 2,day 7 after surgery

  7. Th17/Treg in blood

    Time frame: day 2, day 7 after surgery

  8. Testosterone(Male) in blood

    Time frame: day 2,day 7 after surgery

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Aug 2016 to primary completion in Jan 2019, 29 months.

Of 3,749 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's 29 months is above that.

Counting every sponsor, half of 3,848 studies reached it within 10 months; a quarter within 4 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 3, 2016
First posted
Aug 18, 2016
StartActual
Aug 2016
Primary completionActual
Jan 2019
CompletionActual
Jan 1, 2019
Last update
Jan 25, 2019
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 25, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02871999
Lead sponsor
Xiaonan Cui
Responsible party
Xiaonan Cui (Professor, Chief Physician, The First Affiliated Hospital of Dalian Medical University) — Sponsor-investigator
First posted
Aug 18, 2016
Start date
Aug 2016
Primary completion
Jan 2019
Completion
Jan 1, 2019
Last update
Jan 25, 2019

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion